BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 30843164)

  • 1. Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma.
    Si A; Li J; Yang Z; Xia Y; Yang T; Lei Z; Cheng Z; Pawlik TM; Lau WY; Shen F
    Ann Surg Oncol; 2019 Jun; 26(6):1841-1850. PubMed ID: 30843164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomical sectionectomy based on Takasaki's segmentation for solitary intrahepatic cholangiocarcinoma: a propensity-matched analysis.
    Wang WQ; Li J; Lv X; Wang JL; Zhang EL; Zhang BH; Xiao ZY; Liang BY; Huang ZY
    HPB (Oxford); 2024 Jun; 26(6):753-763. PubMed ID: 38485565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting prognosis in intrahepatic cholangiocarcinoma by the histopathological features.
    Liu H; Lan T; Cai YS; Lyu YH; Zhu J; Xie SN; Hu FJ; Liu C; Wu H
    Asian J Surg; 2024 Jun; 47(6):2589-2597. PubMed ID: 38604849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma.
    Tang SC; Zhang KL; Lin KY; Tang YD; Fu J; Zhou WP; Zhang JX; Kong J; He XL; Sun ZH; Luo C; Liu HZ; Lai YP; Zeng YY
    Hepatol Int; 2024 Apr; 18(2):623-635. PubMed ID: 37880566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative Prognosis of Non-alcoholic Fatty Liver Disease-Associated Intrahepatic Cholangiocarcinoma: a Multi-center Propensity Score Matching Analysis.
    Yu Q; Lei Z; Ma W; Yang F; Tang H; Xiao Q; Tang X; Si A; Yang P; Zhou N; Cheng Z
    J Gastrointest Surg; 2023 Nov; 27(11):2403-2413. PubMed ID: 37582919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is routine lymph node dissection recommended for liver resection of intrahepatic cholangiocarcinoma? A systematic review and meta-analysis.
    Ishii T; Iwaki K; Nakakura A; Yoh T; Uchida Y; Hatano E
    HPB (Oxford); 2024 Jun; 26(6):731-740. PubMed ID: 38580611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical strategy for incidental intrahepatic cholangiocarcinoma in terms of lymph node dissection.
    Kim SH; Han DH; Choi GH; Choi JS; Kim KS
    J Gastrointest Surg; 2024 Jun; 28(6):910-915. PubMed ID: 38561087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Benefit Relative to Treatment Modalities Among Patients with Very Early Intrahepatic Cholangiocarcinoma: an Analysis of the National Cancer Database.
    Endo Y; Sasaki K; Munir MM; Woldesenbet S; Resende V; Rawicz-PruszyƄski K; Waqar U; Mavani P; Katayama E; Yang J; Khalil M; Khan MMM; Kitago M; Pawlik TM
    J Gastrointest Surg; 2023 Oct; 27(10):2103-2113. PubMed ID: 37674099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of liver resection in hepatitis C virus-related intrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Cheo FY; Chan KS; Shelat VG
    World J Virol; 2024 Mar; 13(1):88946. PubMed ID: 38616852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex disparity in clinical characteristics and long-term prognosis after liver resection for patients with intrahepatic cholangiocarcinoma: A propensity score matching analysis.
    Zou Y; Xu X; Wu T; Chen Q; Li Z; Yang Z; Wang K; Shen F
    Heliyon; 2024 May; 10(9):e29910. PubMed ID: 38707344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.
    Bagante F; Spolverato G; Merath K; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Endo I; Pawlik TM
    Surgery; 2019 Dec; 166(6):983-990. PubMed ID: 31326191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.
    Tsilimigras DI; Sahara K; Wu L; Moris D; Bagante F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Moro A; Sasaki K; Aucejo F; Zhang XF; Matsuyama R; Endo I; Pawlik TM
    JAMA Surg; 2020 Sep; 155(9):823-831. PubMed ID: 32639548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of anatomical resection on long-term outcomes after hepatectomy for primary solitary hepatocellular carcinoma with or without preoperative positron emission tomography positivity.
    Cho CW; Kim JM; Lee BH; Lee DS; Yun SS; Choi GS; Joh JW
    Ann Transl Med; 2020 Nov; 8(21):1377. PubMed ID: 33313122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
    Abou-Alfa GK; Macarulla T; Javle MM; Kelley RK; Lubner SJ; Adeva J; Cleary JM; Catenacci DV; Borad MJ; Bridgewater J; Harris WP; Murphy AG; Oh DY; Whisenant J; Lowery MA; Goyal L; Shroff RT; El-Khoueiry AB; Fan B; Wu B; Chamberlain CX; Jiang L; Gliser C; Pandya SS; Valle JW; Zhu AX
    Lancet Oncol; 2020 Jun; 21(6):796-807. PubMed ID: 32416072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma.
    Moro A; Mehta R; Sahara K; Tsilimigras DI; Paredes AZ; Farooq A; Hyer JM; Endo I; Shen F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Soubrane O; Koerkamp BG; Sasaki K; Pawlik TM
    Ann Surg Oncol; 2020 Aug; 27(8):2888-2901. PubMed ID: 32198569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redefining Conditional Overall and Disease-Free Survival After Curative Resection for Intrahepatic Cholangiocarcinoma: a Multi-institutional, International Study of 1221 patients.
    Hu LS; Zhang XF; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
    J Gastrointest Surg; 2020 Dec; 24(12):2756-2765. PubMed ID: 31823320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma.
    Hu LS; Zhang XF; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    Ann Surg Oncol; 2019 Aug; 26(8):2549-2557. PubMed ID: 31020501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation?
    Sahara K; Tsilimigras DI; Merath K; Bagante F; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Matsuyama R; Endo I; Pawlik TM
    Ann Surg Oncol; 2019 Sep; 26(9):2959-2968. PubMed ID: 31152272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma.
    Sun LY; Zhu H; Diao YK; Xing H; Liang L; Li J; Zhou YH; Gu WM; Chen TH; Zeng YY; Pawlik TM; Lau WY; Li C; Shen F; Zhang CW; Yang T
    Ann Transl Med; 2020 Dec; 8(23):1591. PubMed ID: 33437790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Wang MD; Li C; Liang L; Xing H; Sun LY; Quan B; Wu H; Xu XF; Wu MC; Pawlik TM; Lau WY; Shen F; Yang T
    Oncologist; 2020 Oct; 25(10):e1541-e1551. PubMed ID: 32472951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.